Literature DB >> 9858781

In situ characterization of Helicobacter pylori arginase.

G L Mendz1, E M Holmes, R L Ferrero.   

Abstract

The properties of Helicobacter pylori arginase activity in metabolically competent cells and lysates were investigated with the aim of obtaining a better understanding of the nitrogen metabolism of the bacterium. One-dimensional 1H- and 13C-nuclear magnetic resonance spectroscopy, spectrophotometry, radio tracer analysis and protein purification techniques were employed to characterize in situ the first step in the utilization of l-arginine by the bacterium. Arginase activity was associated with the cell-envelope fraction obtained by centrifugation of lysates. A Km of 22+/-3 mM was determined for the enzyme activity, and differences of Vmax were observed between strains. Divalent cations stimulated arginase activity, and the most potent activators were Co2+>Ni2+>Mn2+. The activity was highly specific for l-arginine and did not catabolize analogs recognized by other arginases of prokaryote and eukaryote origin. The Ki of several inhibitors was measured and served also to characterize the enzyme activity. The presence of bicarbonate enhanced the hydrolysis of l-arginine in cell suspensions, but not in lysates or semi-purified enzyme preparations. Amino acid sequence analyses revealed important differences between the deduced structures of H. pylori arginase and those of other organisms. This finding was consistent with experimental data which showed that H. pylori arginase has unique properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858781     DOI: 10.1016/s0167-4838(98)00207-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Crystallization and preliminary crystallographic studies of Helicobacter pylori arginase.

Authors:  Jinyong Zhang; Xiaoli Zhang; Xuhu Mao; Quanming Zou; Defeng Li
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-05-26

2.  Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival.

Authors:  A P Gobert; D J McGee; M Akhtar; G L Mendz; J C Newton; Y Cheng; H L Mobley; K T Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity.

Authors:  D J McGee; F J Radcliff; G L Mendz; R L Ferrero; H L Mobley
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

4.  Expression, purification, and biochemical properties of arginase from Bacillus subtilis 168.

Authors:  Jin-Ju Yu; Ki-Bum Park; Su-Gon Kim; Suk-Heung Oh
Journal:  J Microbiol       Date:  2013-04-27       Impact factor: 3.422

Review 5.  Metabolism and genetics of Helicobacter pylori: the genome era.

Authors:  A Marais; G L Mendz; S L Hazell; F Mégraud
Journal:  Microbiol Mol Biol Rev       Date:  1999-09       Impact factor: 11.056

6.  Isolation and screening of extracellular anticancer enzymes from halophilic and halotolerant bacteria from different saline environments in Iran.

Authors:  Mahdis Zolfaghar; Mohammad Ali Amoozegar; Khosro Khajeh; Hamid Babavalian; Hamid Tebyanian
Journal:  Mol Biol Rep       Date:  2019-04-16       Impact factor: 2.316

Review 7.  Multifactorial etiology of gastric cancer.

Authors:  Jovanny Zabaleta
Journal:  Methods Mol Biol       Date:  2012

Review 8.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

9.  Acid-adaptive genes of Helicobacter pylori.

Authors:  Yi Wen; Elizabeth A Marcus; Uday Matrubutham; Martin A Gleeson; David R Scott; George Sachs
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Presence of active aliphatic amidases in Helicobacter species able to colonize the stomach.

Authors:  Stéphanie Bury-Moné; Stéphane Skouloubris; Catherine Dauga; Jean-Michel Thiberge; Daiva Dailidiene; Douglas E Berg; Agnès Labigne; Hilde De Reuse
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.